CAS: 81801-12-9; Xamoterol

该化合物是一种选择性的乙-1肾上激素激动剂,主要用于治疗心脏衰竭和某些类型的心脏功能障碍,其特点是能够刺激乙型-1肾上激素受体,导致心脏萎缩率增加,并改进心脏输出,而不会显著影响心率,使其与非选择性乙型激动剂有区别.Xamoterol表现出一种有利的药理学特征,因为它可以提高心肌功能,同时最大限度地减少与其他乙型激动剂经常相关的不健康风险.该化合物通常通过口服,其半衰期相对较短,需要全天多剂量才能产生持续治疗效果.其化学结构包括一种苯丙胺单体,有助于其在肾上激素受体中的活动.与任何药物一样,潜在的副作用可能包括淋病,头痛或胃肠紊乱,在有前心血管病的病人中应仔细监测其使用情况.

结构式图片

上下游产品

CAS号76167-36-7 N-[[N-benzyl[3-... | CAS号69630-05-3 N-[2-[N-benzyl[...

合成工艺路线路线简述

    📜Phenyl N-<2-<3-<4-(Benzyloxy)Phenoxy>-2-Hydroxypropyl>Amino>Ethyl>Carbamate置于palladium On Activated Charcoal 氢气,溶剂黄146体系中,用 甲苯 作为反应溶剂,化学反应 19.5H,反应生成 扎莫特罗
    参考文献:.Beta.-Adrenoceptor Stimulant Properties Of Amidoalkylamino-Substituted 1-Aryl-2-Ethanols And 1-(Aryloxy)-2-Propanols
    标题:.Beta.-Adrenoceptor Stimulant Properties Of Amidoalkylamino-Substituted 1-Aryl-2-Ethanols And 1-(Aryloxy)-2-Propanols
    摘要:Parallel Series Of 2-[(2-Amidoethyl)Amino]-1-Arylethanols And 1-[(2-Amidoethyl)Amino]-3-(Aryloxy)-2-Propanols Have Been Prepared,And The Compounds Were Tested As Beta-Adrenoceptor Stimulants On The Heart And Circulation Of The Dog. The Corresponding 2-(Alkylamino)-1-Arylethanols And 3-(Alkylamino)-2-Propanols Have Been Tested For Comparison And The Structure-Activity Relationships (Sar) Examined. The Arylethanols Are Potent Full Agonists,Showing Selectivity For The Heart Relative To Blood Vessels,While The (Aryloxy)Propanols Are Even More Cardioselective And Are Partial Agonists. Within A Narrow Series Of 1-[(Amidoethyl)Amino]-3-(4-Hydroxyphenoxy)-2-Propanols,Careful Examination Of The Sar Of The Amide Group Showed That Great Variation In Cardioselectivity And Degree Of Agonism May Be Produce. From This Study Ici 118587,N-[20[[2-Hydroxy-3-(4-Hydroxyphenoxy)Propyl]Amino]Ethyl]-4-Morpholinecarboxamide,Was Selected For Its High Cardioselectivity And 50% Agonist Properties. This Compound In Under Clinical Evaluation As A Cardiac Stimulant.
    DOI:10.1021/jm00135A015

    海关参考信息

    专利信息


    专利号:US-6683189-B1
    优先权日:1996-02-26
    标 题 :Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
    发明人:DERVAN PETER B; BAIRD ELDON
    权利人:CALIFORNIA INST OF TECHN
    摘要:The present invention describes a novel method for the solid phase synthesis of polyamides containing imidazole and pyrrole carboxamides. The polyamides are prepared on a solid support from aromatic carboxylic acids and aromatic amines with high stepwise coupling yields (>99%), providing milligram quantities of highly pure polyamides. The present invention also describes the synthesis of analogs of the natural products Netropsin and Distamycin A, two antiviral antibiotics. The present invention also describes a novel method for the solid phase synthesis of imidazole and pyrrole carboxamide polyamide-oligonucleotide conjugates. This methodology will greatly increase both the complexity and quantity of minor-groove binding polyamides and minor-groove binding polyamide-oligonucleotide conjugates which can be synthesized and tested.

    专利号:US-9353057-B2
    优先权日:2003-12-30
    标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
    发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
    权利人:XENOPORT INC
    摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-2008287407-A1
    优先权日:2003-12-10
    标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
    发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
    权利人:NITROMED INC
    摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

    专利号:US-8771639-B2
    优先权日:2007-01-05
    标 题 :Methods for preparing composites of substrate-molecular sieve
    发明人:YOON KYUNG BYUNG; LEE JIN SEOK; KIM JAE HYUN; LEE YOUNG JU; JEONG NAK CHEON
    权利人:YOON KYUNG BYUNG; LEE JIN SEOK; KIM JAE HYUN; LEE YOUNG JU; JEONG NAK CHEON; UNIV SOGANG IND UNIV COOP FOUN
    摘要:The present invention relates to a method for preparing composites of substrate-molecular sieve, in particular, to a method for preparing a composite of substrate-molecular sieve, which comprises applying a physical pressure to molecular sieve crystals against a substrate to form a chemical bond between the molecular sieve crystal and the substrate. The present invention requiring no solvents, reactors and other equipments enables molecular sieve crystals to be stably attached to the surface of substrates through various chemical bonds, particularly ionic present invention ensures the synthesis of substrate-molecular sieve composites with enhanced attachment rate, degree of lateral close packing (DCP) and attachment strength in more time-saving and energy-saving manners. The present method works well for molecular sieve crystals with lager sizes (e.g., more than 3 μm) with no generation of parasitic crystals. Furthermore, the present invention shows excellent applicability to large substrates, enabling the mass production of substrate-molecular sieve composites.

    专利号:US-8604213-B2
    优先权日:2008-10-21
    标 题 :Fluorination of aromatic ring systems
    发明人:DIMAGNO STEPHEN
    权利人:DIMAGNO STEPHEN; NUTECH VENTURES
    摘要:This disclosure relates to reagents and methods useful in the synthesis of aryl fluorides, for example, in the preparation of 18 F labeled radiotracers. The reagents and methods provided herein may be used to access a broad range of compounds, including aromatic compounds, heteroaromatic compounds, amino acids, nucleotides, and synthetic compounds.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Nasehi M, Shahbazzadeh S, Ebrahimi-Ghiri M, Zarrindast MR. Bidirectional influence of amygdala β(1)-adrenoceptors blockade on cannabinoid signaling in contextual and auditory fear memory. J Psychopharmacol. 2018 Mar
    1:269881118760654. doi: 10.1177/0269881118760654. [Epub ahead of print] doi: 10.1016/j.neuropharm.2017.01.010. Epub 2017 Jan 13.
    3: Xu D, Wang S, Wu TT, Wang XY, Qian J, Guo Y. Functional cross-talk between the α1- and β1-adrenergic receptors modulates the rapidly activating delayed rectifier potassium current in guinea pig ventricular myocytes. Int J Mol Sci. 2014 Aug 15;15(8):14220-33. doi: 10.3390/ijms150814220. Erratum in: Int J Mol Sci. 2014;15(9):15766.

    合成参考文献


    参考文献:10.1007/bf00171066
    摘要:Schwinger RH, Schulz C, Brixius K, Böhm M, Müller-Ehmsen J, Erdmann E. Effect of epinine on tension of human renal arteries. Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug;354(3):343–7. doi: 10.1007/bf00171066.
    参考文献:10.2165/00003495-199651030-00001
    摘要:Bonarjee VV, Dickstein K. Novel drugs and current therapeutic approaches in the treatment of heart failure. Drugs. 1996 Mar;51(3):347–58. doi: 10.2165/00003495-199651030-00001.
    参考文献:10.1016/s0146-2806(99)90007-5
    摘要:Carson PE. Beta-blocker therapy in heart failure: pathophysiology and clinical results. Curr Probl Cardiol. 1999 Jul;24(7):421–60. doi: 10.1016/s0146-2806(99)90007-5.
    参考文献:10.1016/s0167-5273(01)00447-8
    摘要:van Veldhuisen DJ, Poole-Wilson PA. The underreporting of results and possible mechanisms of ‘negative’ drug trials in patients with chronic heart failure. International Journal of Cardiology. 2001 Aug;80(1):19–27. doi: 10.1016/s0167-5273(01)00447-8.
    参考文献:10.1007/s10286-007-1003-1
    摘要:Freeman R. Current pharmacologic treatment for orthostatic hypotension. Clin Auton Res. 2008 Mar;18 Suppl 1():14–8. doi: 10.1007/s10286-007-1003-1.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知